Status:

COMPLETED

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

Lead Sponsor:

Abbott Medical Devices

Collaborating Sponsors:

Thoratec Corporation

Conditions:

Heart Failure, Congestive

Ventricular Dysfunction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine the safety and effectiveness of the Thoratec HeartMate II Left Ventricular Assist System (LVAS) as Destination Therapy in end-stage heart failure patients who...

Detailed Description

The HeartMate II is a high speed, electric, axial flow, rotary blood pump. The pump drains blood from the left ventricular apex via a rigid inlet cannula and ejects into the aortic root via an outflow...

Eligibility Criteria

Inclusion

  • The following are general criteria; more specific conditions are included in the study protocol:
  • Subjects with advanced heart failure symptoms (NYHA Class IIIB or IV) who are:
  • On optimal medical management and are failing to respond; or
  • In Class III or Class IV heart failure and dependent on IABP and/or inotropes; or
  • Treated with ACE inhibitors or beta-blockers and found to be intolerant.
  • Ineligible for cardiac transplant
  • VO2max \<=14 ml/kg/min
  • LVEF \<=25%

Exclusion

  • The following are general criteria; more specific conditions are included in the study protocol:
  • Evidence of, or risk factors for end-organ dysfunction that would make LVAS implantation futile
  • Existence of factors that would adversely affect patient survival or function of the LVAS
  • Intolerance to anticoagulant or antiplatelet therapies.
  • Existence of any ongoing mechanical circulatory support other than intra-aortic balloon counterpulsation.
  • Participation in any other clinical investigation that is likely to confound study results or affect study outcome

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2012

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00121485

Start Date

February 1 2005

End Date

January 1 2012

Last Update

June 27 2022

Active Locations (47)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (47 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233

2

Mayo Clinic Hospital

Phoenix, Arizona, United States, 85054

3

Sharp Memorial Hospital

San Diego, California, United States, 92123

4

California Pacific Medical Center

San Francisco, California, United States, 94115